JiangXi Tianxin Pharm Co Ltd (603235) — Cash Flow Reinvestment Rate
JiangXi Tianxin Pharm Co Ltd (603235) has a Cash Flow Reinvestment Rate of 0.92x as of December 2025, reinvesting CN¥580.68 Million (capex CN¥580.68 Million ) from operating cash flow of CN¥629.36 Million. Check JiangXi Tianxin Pharm Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
JiangXi Tianxin Pharm Co Ltd Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for JiangXi Tianxin Pharm Co Ltd across 6 annual periods. Explore 603235 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for JiangXi Tianxin Pharm Co Ltd (2020–2025)
Year-by-year capital reinvestment analysis for JiangXi Tianxin Pharm Co Ltd. For live market cap and broader valuation context, see 603235 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.92x | CN¥580.68 Million | CN¥629.36 Million | CN¥580.68 Million | ▼ -82.3% |
| 2024 | 5.22x | CN¥2.61 Billion | CN¥499.66 Million | CN¥1.07 Billion | ▲ +353.7% |
| 2023 | 1.15x | CN¥838.75 Million | CN¥729.21 Million | CN¥535.60 Million | ▼ -2.5% |
| 2022 | 1.18x | CN¥715.84 Million | CN¥606.61 Million | CN¥260.50 Million | ▲ +112.3% |
| 2021 | 0.56x | CN¥455.04 Million | CN¥818.63 Million | CN¥215.50 Million | ▲ +7.7% |
| 2020 | 0.52x | CN¥600.51 Million | CN¥1.16 Billion | CN¥303.04 Million | — |